Insta
Brazil's Federal Health Agency Halts Use Of 12 Million Vaccine Shots Of Chinese Covid Vaccine Sinovac
Swarajya Staff
Sep 05, 2021, 09:52 AM | Updated 09:52 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Anvisa, the federal health regulator of Brazil, on Saturday (4 September) halted the use of over 12 million doses of a COVID-19 vaccine that were produced in an unauthorised plant, reports Reuters.
In a statement, the health regulator stated that the matter was brought to attention a day earlier by Sao Paulo's Butantan institute that 25 batches, or 12.1 million doses, sent to Brazil had been made in the plant.
Notably, Butanan Institute is a biomedical center that has partnered with Sinovac to locally fill and finish the vaccines.
"The manufacturing unit ... was not inspected and was not approved by Anvisa in the authorization of emergency use of the mentioned vaccine," the regulator said.
It further added that the ban was "a precautionary measure to avoid exposing the population to possible imminent risk."
A 90-day-ban has been imposed on the unauthorised plant, and during this period Anvisa will seek to inspect the plant and find out more about the security of the manufacturing process.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.